Os Therapies Incorporated (OSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 03-2003 | 12-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,352 | -1,847 | -6,255 | -630 | -4,400 |
| Depreciation Amortization | 1,453 | 616 | 1,152 | 170 | 710 |
| Accounts payable and accrued liabilities | 1,258 | 446 | N/A | N/A | N/A |
| Other Working Capital | 1,523 | 686 | 947 | -50 | 390 |
| Other Operating Activity | -1,141 | -329 | 363 | -10 | 650 |
| Operating Cash Flow | $-1,259 | $-428 | $-3,793 | $-520 | $-2,650 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | N/A | 0 | -1 | -270 |
| Other Investing Activity | 1 | 1 | 231 | 0 | 2,530 |
| Investing Cash Flow | $1 | $1 | $231 | $-1 | $2,260 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,263 | 775 | N/A | N/A | N/A |
| Other Financing Activity | -127 | -164 | 3,652 | 440 | 440 |
| Financing Cash Flow | $1,136 | $611 | $3,652 | $440 | $440 |
| Beginning Cash Position | 172 | 172 | 81 | 1,330 | 1,280 |
| End Cash Position | 49 | 355 | 172 | 1,250 | 1,330 |
| Net Cash Flow | $-122 | $184 | $91 | $-70 | $40 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,259 | -428 | -3,793 | -520 | -2,650 |
| Free Cash Flow | -1,259 | -428 | -3,793 | -520 | -2,650 |